Logo image of M7U.DE

NYNOMIC AG (M7U.DE) Stock Fundamental Analysis

Europe - FRA:M7U - DE000A0MSN11 - Common Stock

10.65 EUR
+0.05 (+0.47%)
Last: 10/16/2025, 7:00:00 PM
Fundamental Rating

4

Overall M7U gets a fundamental rating of 4 out of 10. We evaluated M7U against 55 industry peers in the Electronic Equipment, Instruments & Components industry. The financial health of M7U is average, but there are quite some concerns on its profitability. M7U has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year M7U has reported negative net income.
M7U had a positive operating cash flow in the past year.
M7U had positive earnings in 4 of the past 5 years.
Each year in the past 5 years M7U had a positive operating cash flow.
M7U.DE Yearly Net Income VS EBIT VS OCF VS FCFM7U.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M 15M

1.2 Ratios

With a Return On Assets value of -5.07%, M7U is not doing good in the industry: 65.45% of the companies in the same industry are doing better.
The Return On Equity of M7U (-7.06%) is worse than 63.64% of its industry peers.
With a Return On Invested Capital value of 0.70%, M7U perfoms like the industry average, outperforming 41.82% of the companies in the same industry.
M7U had an Average Return On Invested Capital over the past 3 years of 7.47%. This is below the industry average of 10.49%.
The 3 year average ROIC (7.47%) for M7U is well above the current ROIC(0.70%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA -5.07%
ROE -7.06%
ROIC 0.7%
ROA(3y)3.69%
ROA(5y)4.37%
ROE(3y)6.44%
ROE(5y)8.2%
ROIC(3y)7.47%
ROIC(5y)7.55%
M7U.DE Yearly ROA, ROE, ROICM7U.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

1.3 Margins

M7U's Operating Margin of 1.22% is in line compared to the rest of the industry. M7U outperforms 45.45% of its industry peers.
M7U's Operating Margin has declined in the last couple of years.
M7U's Gross Margin of 63.16% is fine compared to the rest of the industry. M7U outperforms 78.18% of its industry peers.
In the last couple of years the Gross Margin of M7U has remained more or less at the same level.
Industry RankSector Rank
OM 1.22%
PM (TTM) N/A
GM 63.16%
OM growth 3Y-16.45%
OM growth 5Y-6.15%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.22%
GM growth 5Y0.66%
M7U.DE Yearly Profit, Operating, Gross MarginsM7U.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

5

2. Health

2.1 Basic Checks

M7U has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, M7U has about the same amount of shares outstanding.
M7U has more shares outstanding than it did 5 years ago.
The debt/assets ratio for M7U has been reduced compared to a year ago.
M7U.DE Yearly Shares OutstandingM7U.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
M7U.DE Yearly Total Debt VS Total AssetsM7U.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

An Altman-Z score of 2.79 indicates that M7U is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.79, M7U perfoms like the industry average, outperforming 56.36% of the companies in the same industry.
M7U has a debt to FCF ratio of 6.81. This is a slightly negative value and a sign of low solvency as M7U would need 6.81 years to pay back of all of its debts.
With a Debt to FCF ratio value of 6.81, M7U perfoms like the industry average, outperforming 52.73% of the companies in the same industry.
M7U has a Debt/Equity ratio of 0.14. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.14, M7U is in the better half of the industry, outperforming 74.55% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF 6.81
Altman-Z 2.79
ROIC/WACC0.12
WACC5.96%
M7U.DE Yearly LT Debt VS Equity VS FCFM7U.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M

2.3 Liquidity

A Current Ratio of 3.16 indicates that M7U has no problem at all paying its short term obligations.
M7U's Current ratio of 3.16 is amongst the best of the industry. M7U outperforms 85.45% of its industry peers.
A Quick Ratio of 1.49 indicates that M7U should not have too much problems paying its short term obligations.
M7U has a Quick ratio of 1.49. This is in the better half of the industry: M7U outperforms 74.55% of its industry peers.
Industry RankSector Rank
Current Ratio 3.16
Quick Ratio 1.49
M7U.DE Yearly Current Assets VS Current LiabilitesM7U.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

3

3. Growth

3.1 Past

M7U shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -169.33%.
The Revenue for M7U has decreased by -14.11% in the past year. This is quite bad
Measured over the past years, M7U shows a quite strong growth in Revenue. The Revenue has been growing by 9.57% on average per year.
EPS 1Y (TTM)-169.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-206.97%
Revenue 1Y (TTM)-14.11%
Revenue growth 3Y-0.85%
Revenue growth 5Y9.57%
Sales Q2Q%-11.57%

3.2 Future

M7U is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 23.98% yearly.
M7U is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.30% yearly.
EPS Next Y-34.06%
EPS Next 2Y24.82%
EPS Next 3Y23.98%
EPS Next 5YN/A
Revenue Next Year-5.36%
Revenue Next 2Y-0.08%
Revenue Next 3Y2.38%
Revenue Next 5Y6.3%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
M7U.DE Yearly Revenue VS EstimatesM7U.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M 150M
M7U.DE Yearly EPS VS EstimatesM7U.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for M7U. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 9.81, the valuation of M7U can be described as very reasonable.
Compared to the rest of the industry, the Price/Forward Earnings ratio of M7U indicates a rather cheap valuation: M7U is cheaper than 85.45% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.85. M7U is valued rather cheaply when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 9.81
M7U.DE Price Earnings VS Forward Price EarningsM7U.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of M7U is on the same level as its industry peers.
M7U's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 27.47
EV/EBITDA 11.05
M7U.DE Per share dataM7U.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

M7U's earnings are expected to grow with 23.98% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y24.82%
EPS Next 3Y23.98%

0

5. Dividend

5.1 Amount

M7U does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

NYNOMIC AG

FRA:M7U (10/16/2025, 7:00:00 PM)

10.65

+0.05 (+0.47%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)08-29 2025-08-29
Earnings (Next)11-28 2025-11-28
Inst Owners22.06%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap69.97M
Analysts83.33
Price Target21.68 (103.57%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.13
Dividend Growth(5Y)-3.19%
DP-13.84%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)1.19%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-40.13%
EPS NY rev (3m)-60.43%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-9.84%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 9.81
P/S 0.72
P/FCF 27.47
P/OCF 12.53
P/B 0.74
P/tB 1.51
EV/EBITDA 11.05
EPS(TTM)-1
EYN/A
EPS(NY)1.09
Fwd EY10.19%
FCF(TTM)0.39
FCFY3.64%
OCF(TTM)0.85
OCFY7.98%
SpS14.75
BVpS14.33
TBVpS7.04
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.07%
ROE -7.06%
ROCE 1.06%
ROIC 0.7%
ROICexc 0.79%
ROICexgc 1.51%
OM 1.22%
PM (TTM) N/A
GM 63.16%
FCFM 2.63%
ROA(3y)3.69%
ROA(5y)4.37%
ROE(3y)6.44%
ROE(5y)8.2%
ROIC(3y)7.47%
ROIC(5y)7.55%
ROICexc(3y)9.51%
ROICexc(5y)9.95%
ROICexgc(3y)21.63%
ROICexgc(5y)23.74%
ROCE(3y)11.26%
ROCE(5y)11.38%
ROICexcg growth 3Y-34.01%
ROICexcg growth 5Y-22.69%
ROICexc growth 3Y-26.92%
ROICexc growth 5Y-11.28%
OM growth 3Y-16.45%
OM growth 5Y-6.15%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.22%
GM growth 5Y0.66%
F-Score4
Asset Turnover0.74
Health
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF 6.81
Debt/EBITDA 2.02
Cap/Depr 55.21%
Cap/Sales 3.13%
Interest Coverage 2.82
Cash Conversion 83.52%
Profit Quality N/A
Current Ratio 3.16
Quick Ratio 1.49
Altman-Z 2.79
F-Score4
WACC5.96%
ROIC/WACC0.12
Cap/Depr(3y)106.93%
Cap/Depr(5y)82.07%
Cap/Sales(3y)4.46%
Cap/Sales(5y)3.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-169.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-206.97%
EPS Next Y-34.06%
EPS Next 2Y24.82%
EPS Next 3Y23.98%
EPS Next 5YN/A
Revenue 1Y (TTM)-14.11%
Revenue growth 3Y-0.85%
Revenue growth 5Y9.57%
Sales Q2Q%-11.57%
Revenue Next Year-5.36%
Revenue Next 2Y-0.08%
Revenue Next 3Y2.38%
Revenue Next 5Y6.3%
EBIT growth 1Y-92.11%
EBIT growth 3Y-17.16%
EBIT growth 5Y2.83%
EBIT Next Year-12.66%
EBIT Next 3Y30.84%
EBIT Next 5YN/A
FCF growth 1Y265.93%
FCF growth 3Y-38.75%
FCF growth 5Y11.02%
OCF growth 1Y321.04%
OCF growth 3Y-25%
OCF growth 5Y12.14%